|
|
|
||
|
Top Stories 27th
Annual Convention (7/25/08)
Convention
Lecture Legislation Journal
of the American Naturopathic Medical Association (JANMA) Facts |
ANMA ONLINE REFERENCES
Natural B Vitamins Are Better Than Synthetic Ones By: Robert J. Thiel, Ph.D., Naturopath
REFERENCES [1] The United States Pharmacopeial Convention. USAN and USP Dictionary of Drug Names. Mack Printing, Easton (PA),1986 [2] Olson JA. Vitamin A, retinoids, and carotenoids. In Modern Nutrition in Health and Disease, 8th ed. Lea & Febiger, Phil.,1994:287-307 [3] Farrell PA, Roberts RJ. Vitamin E. In Modern Nutrition in Health and Disease, 8th ed. Lea & Febiger, Phil.,1994:326-358 [4] Jacob RA. Vitamin C. In Modern Nutrition in Health and Disease, 9th ed. William & Wilkins, Balt.,1999:467-483 [5] Tanphaichitr V. Thiamin. In Modern Nutrition in Health and Disease, 8th ed. Lea & Febiger, Phil.,1994:359-365 [6] Macrae R, Robson RK, Sadler MJ. Encyclopedia of Food Science and Nutrition. Academic Press, New York, 1993 [7] Haynes W. Chemical Trade Names and Commercial Synonyms, 2nd ed. Van Nostrand Co., New York, 1955 [8] Hui JH. Encyclopedia of Food Science and Technology. John Wiley, New York, 1992 [9] Tanphaichitr V. Thiamin. In Modern Nutrition in Health and Disease, 9th ed. William & Wilkins, Balt.,1999:381-389 [10] Kimura M, Itokawa Y, Fujiwara M. Cooking losses of thiamin in food and its nutritional significance. J Nutr Sci Vitaminol, 1990;36(S1):S17:S24 [11] Vinson J, Bose P, Lemoine L, Hsiao KH. Bioavailability studies. In Nutrient Availability: Chemical and Biological Aspects. Royal Society of Chemistry, Cambridge (UK) 1989:125-127 [12] McCormick DB, Riboflavin. In Modern Nutrition in Health and Disease, 9th ed. William & Wilkins, Balt.,1999:391-399 [13] McCormick DB. Riboflavin. In Modern Nutrition in Health and Disease, 8th ed. Lea & Febiger, Phil.,1994:366-375 [14] Kanno C, Kanehara N, Shirafuji K, Tanji R, Imai T. Binding form of vitamin B2 in bovine milk: its concentrations, distribution, and binding linkages. J Nutr Sci Vitaminol, 1991;37(1):15-27 [15] Swenseid ME and Jacob RA. Niacin. In Modern Nutrition in Health and Disease, 8th ed. Lea and Febiger, Phil.,1994:376-382 [16] Cervantes-Lauren D, McElvaney NG, Moss J. Niacin. In Modern Nutrition in Health and Disease, 9th ed. Williams & Wilkins, Balt.,1999:401-411 [17] Williams AW, Erdman JW. Food processing: nutrition, safety, and quality balances. In Modern Nutrition in Health and Disease, 9th ed. William & Wilkins, Balt.,1999:1813-1821 [18] Tenney L. Health Handbook. Woodland Books, Provo (UT), 1987 [19] Plesofsky-Vig N. Pantothenic acid and Coenzyme A. In Modern Nutrition in Health and Disease, 8th ed. Lea & Febiger, Phil.,1994:395-401 [20] Plesofsky-Vig N. Pantothenic acid. In Modern Nutrition in Health and Disease, 9th ed. William & Wilkins, Balt.,1999:423-432 [21] Leklem JE. Vitamin B6. In Modern Nutrition in Health and Disease, 8th ed. Lea & Febiger, Phil.,1994:383-394 [22] Ensminger AH, Ensminger ME, Konlade JE, Robson JRK. Food & Nutrition Encyclopedia, 2nd ed. CRC Press, New York, 1993 [23] Leklem JE. Vitamin B6. In Modern Nutrition in Health and Disease, 9th ed. William & Wilkins, Balt.,1999:413-421 [24] Nakano H, McMahon LG, Gregory JF. Pyridoxine-5’-beta-glucoside exhibits incomplete bioavailability as a source of vitamin B-6 and partially inhibits the utilization of co-ingested pyridoxine in humans. J Nutr,1997;127(8):1508-1513 [25] Whitney EN, Rolfes S. Understanding Nutrition, 7th ed. West Publishing, St. Paul, 1996 [26] Herbert V. Folic Acid In Modern Nutrition in Health and Disease, 9th ed. Williams & Wilkins, Balt.,1999:433-446 [27] Crane NT, et al. Evaluating food fortification options: general principles revisited with folic acid. Am J Public Health, 1995;85(5):660-666 [28] Tucker KL, Mahnken B, Wilson PW, Jaques P, Selhub J. Folic acid fortification. Potential benefits and risks for the elderly population. JAMA, 1997;276(23):1879-1885 [29] Maurer K. Group urges increased folic acid fortification. Family Practice News, October 15, 1996:11 [30] Mervyn L. The B Vitamins. Thorsons, Wellingborough (UK), 1981 [31] Herbert V, Das KC. Folic acid and vitamin B12. In Modern Nutrition in Health and Disease, 8th ed. Lea & Febiger, Phil.,1994:402-425 [32] Weir DG, Scott JM. Vitamin B12 "cobalamin". In Modern Nutrition in Health and Disease, 9th ed. William & Wilkins, Balt.,1999:447-458 [33] Ishida A, Kanefusa H, Fujita H, Toraya T. Microbiological activities of nucleotide loop-modified analogues of vitamin B12. Arch Microbiol,1994;161(4):293-299 [34] Tandler B, Krhenbul S, Brass EP. Unusual mitochondria in the hepatocytes of rats treated with a vitamin B12 analogue. Anat Rec,1991;231(1):1-6 [35] Erdman JW, Poneros-Schneir AG. Factors affecting the nutritive value in processed foods. In Modern Nutrition in Health and Disease, 8th ed. Lea & Febiger, Phil.,1994:1569-1578 [36] Bollet AJ. Politics and pellagra: the epidemic of pellagra in the U.S. in the early twentieth century. Yale J Biol Med, 1992;65(3):211-221 [37] Andrews, et al. Food preservation using ionizing radiation. Rev Environ Contam Toxicol, 1998;154(1):1-53 [38] Ghebremeskel K, Crawford MA. Nutrition and health in relation to food production and processing. Nutr Health, 1994;9(4):237-253
Application of Genomeceuticals
to the By: Mark Brudnak, B.S., N.D., Ph.D. REFERENCES 1. Turner M., Bamby G., Bailey A. Genetic clues to the biological basis of autism. Mol Med Today 2000; 6: 238-244. 2. Haileselassie S. S., Lee B. H., Gibbs B. F. Purification and identification of potentially bioactive peptides from enzyme-modified cheese. J Dairy Sci 1999; 82: 1612-1617 3. Brudnak M. A. Genomic Multi-level nutrient-sensing pathways. Med Hypothese 2001; 4. Kirkman Laboratories, Wilsonville, OR, USA. Personal Communications. 5. Smith M. W., James P.S., Peacock M.A. Galactose effects on enterocyte differentation in the mouse jejunum. Biochim Biophys Acta 1991; 1093: 1446. 6. Wang J., Liu R., Hawkins M., Barzilai N., Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 1998; 393: 684-688. 7. Bermpohl F., Loster K., Reutter w., Baum O. Rat dipeptidyl peptidase IV (DPP IV) exhibits endopeptidase activity with specificity for denatured fibrillar collagens. FEBS Lett 1998 428: 152-156. 8. Lefrancois L., Fuller B., Huleatt J. W., Olson S., Puddington L. On the front lines: intraepathelial Lymphocytes as primary effectors of intestinal immunity. Springer Semin Immunopathol 1997; 18: 463-475. 9. Suzuki Y., Erickson R. H., Sedlmayer A., Chang S. K., Ikehara Y., Kim Y. S. Dietary regulation of rat intestinal angiotensin-converting enzyme and dipetidyl peptidase IV. Am J Physiol 1993; 264: G1153-G1159. 10. Harrington L.F., Galvan M., Baum L. G., Altman J. D., Ahmed R. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J Exp Mol 2000; 191: 1241-1246. 11. Chiravuri M., Lee H., Hurta S. L., Huber B. T. Homodimerization via a leucine zipper motif is required for enzymatic activity of quiescent cell proline dipeptidase. J Biol Chem 2001; 275(35): 26994-26999. 12. Underwood R., Chiravuri M., Lee H. et al. Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase. J Biol Chem 1999; 274: 34053-34058. 13. Kaba A., Ilunga L. A., Chany C. Role of sarcolectin (SCL) and interferons in coordinated T cell clonal expansion. J Interferon Cytokine Res 2000; 20: 519-525. 14. Amdt M., reinhold D., Lendeckel U. et al. Specific inhibitors of dipeptidyl peptidase IV suppress mRNA expression of DP IV/ CD26 and cytokines. Adv Exp Med Biol 2000; 477: 139-143. 15. Frey A., Neutra M. R. Targeting of mucosal vaccines to Peyer’s patch M cells. Behring Inst Mitt 1997; 98: 376-389. 16. Adams D. S., Nathans R., Pero s. C., Sen A., Wakshull E. Activation of a rel-A/CEBP-beta-related transcription factor heteromer by PGG-glucan in a murinc monocytic cell line. J Cell Biochem 2000; 77: 221-233. 17. Hetland G., Lovik M., Wiker H. G. Protective Effect of B-Glucan Against Mycobacterium bovis, BCG infection in BALB/c mice. Scand J Immunol 1998; 47: 548-553. 18. Megson M. N. Is autism a G-alpha protein defect reversible with natural vitamin A? Med Hypotheses 2000; 54(6):979-983. 19. Fischer S., Scheffler A., Kabelitz D. Stimulation of the specific immune system by mistletoe extracts. Anticancer Drugs 1997; 8 (suppl): 533-537. 20. Granchi D., Verri E., Ciapetti G. et al. Effects of chromium extract on cytokine release by mononuclear cells. Biomaterials 1998; 19: 283-291. 21. Mas C., Bourgeois F., Bulfone A., Levacher B., Mugnier C., Simonneau M. Cloning and expression analysis of a novel gene, RP42, mapping to an autism susceptibility locus on 6q16. Genomics 2000; 65: 70-74. |
||
